Analysis of the role of viral encephalitis in the development of epileptic seizures and epilepsy

Authors

DOI:

https://doi.org/10.15587/2519-4798.2020.217557

Keywords:

central nervous system, seizures, epilepsy, encephalitis, viral infections, pathogenesis, risk factors, forecasting, treatment, review

Abstract

The aim – to determine the role of viral lesions of the central nervous system (CNS) in the development of epileptic seizures and epilepsy.

Materials and methods: analysis of scientific literature data. The review discusses the role of non-epidemic viral encephalitis and human immunodeficiency virus in the development of acute epileptic seizures and epilepsy; epidemiological data and risk factors.

Results. Viral infections are often complicated by acute (early) epileptic seizures and causes the risk of further epilepsy. The mechanisms of development of early and late seizures differ. Except herpetic encephalitis, in which risk of epilepsy in early seizures is up to 60 %, the risk of late seizures in other viral encephalitis hasn't been determined. Timely treatment of viral infections and early seizures reduces the risk of epilepsy. Treatment of epilepsy with infectious lesions of the central nervous system and other types of symptomatic epilepsy is similar, and the antiepileptic drug is determined by the semiology of seizures. The interaction between it and anti-infective drugs can change the concentration in the blood of each of them, which will lead to reduced effectiveness or toxicity. This is especially important for individuals with human immunodeficiency virus infection in whom antiretroviral drugs have significant interactions with antiepileptic drugs. Since epileptic activity of the brain is associated with the severity and complications of the underlying infection, early aggressive therapy prevents the development of late seizures and epilepsy.

Conclusions. CNS infections account for 15 % of all newly diagnosed symptomatic epileptic seizures. The 20-year risk of unprovoked seizures and epilepsy after CNS infections ranges from 2.4 % to 22 %. The risk depends on the etiology, location of the lesion and the severity; it is high in herpes-associated encephalitis

Author Biographies

Tetyana Litovchenko, Kharkiv Medical Academy of Postgraduate Education Amosova str., 58, Kharkiv, Ukraine, 61176

MD, Professor, Head of Department

Department of Neurology and Child Neurology

Oleksandr Bilchenko, Kharkiv Medical Academy of Postgraduate Education Amosova str., 58, Kharkiv, Ukraine, 61176

MD, Professor, Head of Department

Department of Therapy, Nephrology and General Practice-Family Medicine

Vladimir Malakhov, Kharkiv Medical Academy of Postgraduate Education Amosova str., 58, Kharkiv, Ukraine, 61176

MD, Professor, Head of Department

Department of Medical Rehabilitation, Sports Medicine and Physical Therapy

Olga Dubenko, Kharkiv Medical Academy of Postgraduate Education Amosova str., 58, Kharkiv, Ukraine, 61176

MD, Professor

Department of Neuropathology and Neurosurgery

Olga Sukhonosova, Kharkiv Medical Academy of Postgraduate Education Amosova str., 58, Kharkiv, Ukraine, 61176

MD, Professor

Department of Neurology and Pediatric Neurology

Viktoriia Bokatuieva, Institute of Neurology, Psychiatry and Narcology of National Academy of Medical Sciences of Ukraine Akademika Pavlova str., 46, Kharkiv, Ukraine, 61068

Researcher

Department of Vascular Pathology of the Brain and Rehabilitation

Marianna Markova, Kharkiv Medical Academy of Postgraduate Education Amosova str., 58, Kharkiv, Ukraine, 61176

MD, Professor

Department of Sexology, Medical Psychology, Medical and Psychological Rehabilitation

Vadym Nikonov, Kharkiv Medical Academy of Postgraduate Education Amosova str., 58, Kharkiv, Ukraine, 61176

Doctor of medical sciences, professor, Head of the Department

Department of Emergency Care and Disaster Medicine

References

  1. World Health Organization. Epilepsy fact sheet no. 999 January 2009. Available at: thttp://www.who.int/mediacentre/factsheets/fs999/en/index.html Last accessed: 23.10.2020
  2. Shorvon, S. D., Perukka, E., Engel, J. (Eds.) (2009). The treatment of epilepsy. Blackwell Publishing Ltd, 1075. doi: http://doi.org/10.1002/9781444316667
  3. Sander, J. W., Hart, Y. M., Johnson, A. I., Shorvon, S. D. (1990). Medical science. National general practice Study of Epilepsy: newly diagnosed epileptic seizures in general population. Lancet, 336 (8726), 1267–1271. doi: http://doi.org/10.1016/0140-6736(90)92959-l
  4. Bhalla, D., Godet, B., Druet-Cabanac, M., Preux, P.-M. (2011). Etiologies of epilepsy: a comprehensive review. Expert Review of Neurotherapeutics, 11 (6), 861–876. doi: http://doi.org/10.1586/ern.11.51
  5. Fujiwara, T., Shigematsu, H. (2004). Etiologic factors and clinical features of symptomatic epilepsy: Focus on pediatric cases. Psychiatry and Clinical Neurosciences, 58 (3), S9–S12. doi: http://doi.org/10.1111/j.1440-1819.2004.01244_3.x
  6. Singh, T. D., Fugate, J. E., Hocker, S. E., Rabinstein, A. A. (2014). Postencephalitic epilepsy: Clinical characteristics and predictors. Epilepsia, 56 (1), 133–138. doi: http://doi.org/10.1111/epi.12879
  7. Ziai, W. C., Lewin, J. J. (2008). Update in the Diagnosis and Management of Central Nervous System Infections. Neurologic Clinics, 26 (2), 427–468. doi: http://doi.org/10.1016/j.ncl.2008.03.013
  8. Duncan, J. S., Shorvon, S. D., Fish, D. R. (1995). Clinical Epilepsy. London: Churchill Livingstone, 540.
  9. Shorvon, S. D., Andermann, F., Guerrini, R. (2011). The Causes of Epilepsy. Cambridge: Cambridge Univers. press, 787. doi: http://doi.org/10.1017/cbo9780511921001
  10. Annegers, J. F., Hauser, W. A., Beghi, E., Nicolosi, A., Kurland, L. T. (1988). The risk of unprovoked seizures after encephalitis and meningitis. Neurology, 38 (9), 1407–1410. doi: http://doi.org/10.1212/wnl.38.9.1407
  11. Cardarelli, W. J., Smith, B. J. (2010). The burden of epilepsy to patients and payers. The American Journal of Managed Care, 16, S331–S336.
  12. Marks, D. A., Kim, J., Spencer, D. D., Spencer, S. S. (1992). Characteristics of intractable seizures following meningitis and encephalitis. Neurology, 42 (8), 1513–1518. doi: http://doi.org/10.1212/wnl.42.8.1513
  13. Nieto Barrera, M. (2002). Aspectos clínicos, neurorradiológicos y evolutivos de las epilepsias catastróficas postencefalíticas. Revista de Neurología, 35 (S1), 30–38. doi: http://doi.org/10.33588/rn.35s1.2002183
  14. Trinka, E., Dubeau, F., Andermann, F. Bastos, A., Hui, A., Li, L. M. et. al. (2000). Clinical findings, imaging characteristics and outcome in catastrophic post-encephalitic epilepsy. Epileptic Disord, 2, 153–162.
  15. Chen, Y.-J., Fang, P.-C., Chow, J. C. (2006). Clinical Characteristics and Prognostic Factors of Postencephalitic Epilepsy in Children. Journal of Child Neurology, 21 (12), 1047–1051. doi: http://doi.org/10.1177/7010.2006.00223
  16. Zelano, J., Westman, G. (2020). Epilepsy after brain infections in adults: A register-based population-wide study. Neurology. doi: http://doi.org/10.1212/wnl.0000000000010954
  17. Granerod, J., Crowcroft, N. S. (2007). The epidemiology of acute encephalitis. Neuropsychological Rehabilitation, 17 (4-5), 406–428. doi: http://doi.org/10.1080/09602010600989620
  18. Singhi, P. (2011). Infectious causes of seizures and epilepsy in the developing world. Developmental Medicine & Child Neurology, 53 (7), 600–609. doi: http://doi.org/10.1111/j.1469-8749.2011.03928.x
  19. Jmor, F., Emsley, H. C., Fischer, M., Solomon, T., Lewthwaite, P. (2008). The incidence of acute encephalitis syndrome in Western industrialised and tropical countries. Virology Journal, 5 (1), 134–136. doi: http://doi.org/10.1186/1743-422x-5-134
  20. Whitley, R. J. (2006). Herpes simplex encephalitis: Adolescents and adults. Antiviral Research, 71 (2-3), 141–148. doi: http://doi.org/10.1016/j.antiviral.2006.04.002
  21. Elbers, J. M., Bitnun, A., Richardson, S. E., Ford-Jones, E. L., Tellier, R., Wald, R. M. et. al. (2007). A 12-Year Prospective Study of Childhood Herpes Simplex Encephalitis: Is There a Broader Spectrum of Disease? Pediatrics, 119 (2), e399–e407. doi: http://doi.org/10.1542/peds.2006-1494
  22. Solomon, T., Hart, I. J., Beeching, N. J. (2007). Viral encephalitis: a clinical guide. Practical Neurology, 7, 288–305. doi: http://doi.org/10.1136/jnnp.2007.129098
  23. Yamada, S., Kameyama, T., Nagaya, S., Hashizume, Y., Yoshida, M. (2003). Relapsing herpes simplex encephalitis: pathological confirmation of viral reactivation. Journal of Neurology, Neurosurgery & Psychiatry, 74 (2), 262–264. doi: http://doi.org/10.1136/jnnp.74.2.262
  24. Kim, M. A., Park, K. M., Kim, S. E., Oh, M. K. (2008). Acute symptomatic seizures in CNS infection. European Journal of Neurology, 15, 38–41. doi: http://doi.org/10.1111/j.1468-1331.2007.01996.x
  25. Doja, A., Bitnun, A., Ford Jones, E. L., Richardson, S., Tellier, R., Petric, M. et. al. (2006). Pediatric Epstein-Barr Virus – Associated Encephalitis: 10-Year Review. Journal of Child Neurology, 21 (5), 384–391. doi: http://doi.org/10.1177/08830738060210051101
  26. Hung, K. L., Liao, H. T., Tsai, M. L. (2000). Epstein-Barr virus encephalitis in children. Acta Paediatr Taiwan, 41, 140–146.
  27. Häusler, M., Schaade, L., Kemény, S., Schweizer, K., Schoenmackers, C., Ramaekers, V. T. (2002). Encephalitis related to primary varicella-zoster virus infection in immunocompetent children. Journal of the Neurological Sciences, 195 (2), 111–116. doi: http://doi.org/10.1016/s0022-510x(02)00017-5
  28. Perry, R. T., Halsey, N. A. (2004). The Clinical Significance of Measles: A Review. The Journal of Infectious Diseases, 189 (1), 4–16. doi: http://doi.org/10.1086/377712
  29. Cherry, J., Demmler-Harrison, G., Kaplan, Sh., Steinbach, W., Hotez, P. (2017). Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Elsevier, 3000.
  30. Hviid, A., Rubin, S., Mühlemann, K. (2008). Mumps. The Lancet, 371 (9616), 932–944. doi: http://doi.org/10.1016/s0140-6736(08)60419-5
  31. Vincent, A., Irani, S. R., Lang, B. (2011). Potentially pathogenic autoantibodies associated with epilepsy and encephalitis in children and adults. Epilepsia, 52, 8–11. doi: http://doi.org/10.1111/j.1528-1167.2011.03224.x
  32. Granerod, J., Cunningham, R., Zuckerman, M., Mutton, K., Davies, N. W. S., Walsh, A. L. et. al. (2010). Causality in acute encephalitis: defining aetiologies. Epidemiology and Infection, 138 (6), 783–800. doi: http://doi.org/10.1017/s0950268810000725
  33. Pillai, S. C., Mohammad, S. S., Hacohen, Y., Tantsis, E., Prelog, K., Barnes, E. H. et. al. (2015). Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody-associated encephalitis in childhood: Clinical and etiologic risk factors. Epilepsia, 57 (1), e7–e11. doi: http://doi.org/10.1111/epi.13253
  34. Armangue, T., Moris, G., Cantarín-Extremera, V., Conde, C. E., Rostasy, K., Erro, M. E. et. al. (2015). Autoimmune post–herpes simplex encephalitis of adults and teenagers. Neurology, 85 (20), 1736–1743. doi: http://doi.org/10.1212/wnl.0000000000002125
  35. Bradshaw, M. J., Pawate, S., Lennon, V. A., Bloch, K. C., Brown, K. M. (2015). Herpes simplex virus 1 encephalitis associated with voltage-gated calcium channel autoimmunity. Neurology, 85 (24), 2176–2177. doi: http://doi.org/10.1212/wnl.0000000000002218
  36. Titulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T. et. al. (2013). Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. The Lancet Neurology, 12 (2), 157–165. doi: http://doi.org/10.1016/s1474-4422(12)70310-1
  37. Spatola, M., Dalmau, J. (2017). Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis. Current Opinion in Neurology, 30 (3), 345–353. doi: http://doi.org/10.1097/wco.0000000000000449
  38. Murthy, J. M. K., Prabhakar, S. (2008). Bacterial meningitis and epilepsy. Epilepsia, 49, 8–12. doi: http://doi.org/10.1111/j.1528-1167.2008.01750.x
  39. Gaspard, N., Foreman, B. P., Alvarez, V., Cabrera Kang, C., Probasco, J. C. et. al. (2015). New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology, 85, 1604–1613. doi: http://doi.org/10.1212/wnl.0000000000001940

Downloads

Published

2020-12-25

How to Cite

Litovchenko, T., Bilchenko, O., Malakhov, V., Dubenko, O., Sukhonosova, O., Bokatuieva, V., Markova, M., & Nikonov, V. (2020). Analysis of the role of viral encephalitis in the development of epileptic seizures and epilepsy. ScienceRise: Medical Science, (6 (39), 4–9. https://doi.org/10.15587/2519-4798.2020.217557

Issue

No. 6 (39) (2020)

Section

Medical Science

License

Copyright (c) 2020 Tetyana Litovchenko, Oleksandr Bilchenko, Vladimir Malakhov, Olga Dubenko, Olga Sukhonosova, Viktoriia Bokatuieva, Marianna Markova

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.